Home » Events & Activities » Other activities » Equality in Cancer Care – educational project 2025/2026

Equality in Cancer Care – educational project 2025/2026

 

Background

The increasing awareness of health disparities has brought to light the urgent need to promote equity in cancer care.

Social determinants of health — including socioeconomic status, race, ethnicity, and access to healthcare resources — play a critical role in shaping outcomes for patients, caregivers, and healthcare professionals.

Advancing health equity in oncology requires identifying and addressing these systemic barriers, expanding access to high-quality care, and ensuring that every patient receives the treatment they need and deserve, regardless of their background or circumstances.

 

Format

This multi-step educational programme is designed to explore the challenges surrounding cancer health equity and to provide data, insights, and practical tools to support progress in this critical area.

The initiative includes the following:

 

Faculty

Chairs:

Joseph Gligorov, Hospital Tenon Ap-Hp and President of the Mediterranean Association for Radiotherapy Oncology and Medical Oncology (AROME), Paris, FR and Dorothy Keefe, Cancer Australia, Surry Hills NSW, AU

Experts:

May Abdel-Wahab, Division of Human Health at the International Atomic Energy Agency (IAEA), Vienna, AT

Nicolò Matteo Luca Battisti, The Royal Marsden NHS Foundation Trust, Sutton, UK and European Cancer Organisation, Brussels, BE

Susan Mary Henshall, World Health Organization, Geneva, CH

Abiola Ibraheem, University of Illinois and VP North America for the African Organisation for Research and Training in Cancer (AORTIC), Chicago, US

Dan Milner, Chief Medical Officer of the American Society for Clinical Pathology and Executive Director of the UICC’s ATOM Coalition, US

Stewart O’Callaghan, OUTpatients, London, UK

 

Task Force Programme

 

Acknowledgments

AstraZeneca and Gilead have provided sponsorship grants towards this independent activity.

 

Next Steps

Further information on the Task Force developments and the forthcoming paper will be made available on this page in due course.